John M. Lambert
12Patents
10h-index
16Co-inventors
69Inventor score
Filing activity: Jul 10, 1984 → Sep 9, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5208020A | Cytotoxic agents comprising maytansinoids and their therapeutic use | Emerging Cross-Sectional Technologies | 747 | Expired |
| US5416064A | Cytotoxic agents comprising maytansinoids and their therapeutic use | Emerging Cross-Sectional Technologies | 487 | Expired |
| US4569789A | Acid-cleavable compound, use in protein conjugates and drug delivery systems | Chemistry; Metallurgy | 205 | Expired |
| US4625014A | Cell-delivery agent | Emerging Cross-Sectional Technologies | 103 | Expired |
| US4618492A | Acid-cleavable compound | Chemistry; Metallurgy | 43 | Expired |
| US4542225A | Acid-cleavable compound | Chemistry; Metallurgy | 43 | Expired |
| US4764368A | Acid-cleavable compound | Chemistry; Metallurgy | 37 | Expired |
| US5239062A | Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity | Human Necessities | 31 | Expired |
| US4888415A | Gelonin immunotoxin | Emerging Cross-Sectional Technologies | 31 | Expired |
| US5395924A | Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity | Human Necessities | 27 | Expired |
| US8137669B2 | Elimination of heterogeneous or mixed cell population in tumors | Chemistry; Metallurgy | 7 | Active |
| US8388960B2 | Elimination of heterogeneous or mixed cell population in tumors | Chemistry; Metallurgy | 7 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.